The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Mechanism of action of interferon and ribavirin in treatment of hepatitis C
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Gonçales, F. L., Häussinger, D., Diago, M., Carosi, G., Dhumeaux, D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020047 · Cited by 6,389
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., Goodman, Z. D., Koury, K., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,029
Hadziyannis, S. J., Sette, H., Morgan, T. R., Balan, V., Diago, M., Marcellin, P., Ramadori, G., Bodenheimer, H., Bernstein, D., Rizzetto, M., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-5-200403020-00010 · Cited by 2,836
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Kräusslich, H.-G., Mizokami, M., et al. (2005) · Nature Medicine · doi:10.1038/nm1268 · Cited by 2,754
Complete Replication of Hepatitis C Virus in Cell Culture
Lindenbach, B. D., Evans, M. J., Syder, A. J., Wölk, B., Tellinghuisen, T. L., Liu, C. C., Maruyama, T., Hynes, R. O., Burton, D. R., McKeating, J. A., et al. (2005) · Science · doi:10.1126/science.1114016 · Cited by 2,238
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
Neumann, A. U., Lam, N. P., Dahari, H., Gretch, D. R., Wiley, T. E., Layden, T. J., & Perelson, A. S. (1998) · Science · doi:10.1126/science.282.5386.103 · Cited by 2,113
Robust hepatitis C virus infection in vitro
Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D. R., Wieland, S. F., Uprichard, S. L., Wakita, T., & Chisari, F. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503596102 · Cited by 1,709
Immunology of hepatitis B virus and hepatitis C virus infection
Rehermann, B., & Nascimbeni, M. (2005) · Nature Reviews Immunology · doi:10.1038/nri1573 · Cited by 1,627
Viruses and interferon: a fight for supremacy
Katze, M. G., He, Y., & Gale, M. (2002) · Nature Reviews Immunology · doi:10.1038/nri888 · Cited by 1,419
Efficient Initiation of HCV RNA Replication in Cell Culture
Blight, K. J., Kolykhalov, A. A., & Rice, C. M. (2000) · Science · doi:10.1126/science.290.5498.1972 · Cited by 1,412
Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus
Lechner, F., Wong, D. K. H., Dunbar, P. R., Chapman, R., Chung, R. T., Dohrenwend, P., Robbins, G., Phillips, R., Klenerman, P., & Walker, B. D. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.9.1499 · Cited by 1,269
Peginterferon Alfa-2a in Patients with Chronic Hepatitis C
Zeuzem, S., Feinman, S. V., Rasenack, J., Heathcote, E. J., Lai, M.-Y., Gane, E., O'Grady, J., Reichen, J., Diago, M., Lin, A., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432301 · Cited by 1,220
Genomic analysis of the host response to hepatitis C virus infection
Su, A. I., Pezacki, J. P., Wodicka, L., Brideau, A. D., Supekova, L., Thimme, R., Wieland, S., Bukh, J., Purcell, R. H., Schultz, P. G., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202608199 · Cited by 1,161
Enomoto, N., Sakuma, I., Asahina, Y., Kurosaki, M., Murakami, T., Yamamoto, C., Ogura, Y., Izumi, N., Marumo, F., & Sato, C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601113340203 · Cited by 998
Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha Interferon
Hoofnagle, J. H., Mullen, K. D., Jones, D. B., Rustgi, V., Di Bisceglie, A., Peters, M., Waggoner, J. G., Park, Y., & Jones, E. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612183152503 · Cited by 972
Self-citationSen, G. C. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.255 · Cited by 968
Functional classification of interferon-stimulated genes identified using microarrays
de Veer, M. J., Holko, M., Frevel, M., Walker, E., Der, S., Paranjape, J. M., Silverman, R. H., & Williams, B. R. G. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.6.912 · Cited by 900
Sumpter, R., Loo, Y.-M., Foy, E., Li, K., Yoneyama, M., Fujita, T., Lemon, S. M., & Gale, M. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.2689-2699.2005 · Cited by 898
Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and Cirrhosis
Heathcote, E. J., Shiffman, M. L., Cooksley, W. G. E., Dusheiko, G. M., Lee, S. S., Balart, L., Reindollar, R., Reddy, R. K., Wright, T. L., Lin, A., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432302 · Cited by 874
RNA virus error catastrophe: Direct molecular test by using ribavirin
Crotty, S., Cameron, C. E., & Andino, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111085598 · Cited by 849
The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen
Crotty, S., Maag, D., Arnold, J. J., Zhong, W., Lau, J. Y. N., Hong, Z., Andino, R., & Cameron, C. E. (2000) · Nature Medicine · doi:10.1038/82191 · Cited by 820
Gale, M. J., Korth, M. J., Tang, N. M., Tan, S.-L., Hopkins, D. A., Dever, T. E., Polyak, S. J., Gretch, D. R., & Katze, M. G. (1997) · Virology · doi:10.1006/viro.1997.8493 · Cited by 810
Treatment of Acute Hepatitis C with Interferon Alfa-2b
Jaeckel, E., Cornberg, M., Wedemeyer, H., Santantonio, T., Mayer, J., Zankel, M., Pastore, G., Dietrich, M., Trautwein, C., & Manns, M. P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011232 · Cited by 800
Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease
Foy, E., Li, K., Wang, C., Sumpter, R., Ikeda, M., Lemon, S. M., & Gale, M. (2003) · Science · doi:10.1126/science.1082604 · Cited by 788
Inhibition of the Interferon- Inducible Protein Kinase PKR by HCV E2 Protein
Taylor, D. R., Shi, S. T., Romano, P. R., Barber, G. N., & Lai, M. M. C. (1999) · Science · doi:10.1126/science.285.5424.107 · Cited by 733
Lindsay, K. L., Trepo, C., Heintges, T., Shiffman, M. L., Gordon, S. C., Hoefs, J. C., Schiff, E. R., Goodman, Z. D., Laughlin, M., Yao, R., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.26371 · Cited by 668
Gale, M., Blakely, C. M., Kwieciszewski, B., Tan, S.-L., Dossett, M., Tang, N. M., Korth, M. J., Polyak, S. J., Gretch, D. R., & Katze, M. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.5208 · Cited by 605
Marcellin, P., Boyer, N., Gervais, A., Martinot, M., Pouteau, M., Castelnau, C., Kilani, A., Areias, J., Auperin, A., Benhamou, J. P., et al. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-10-199711150-00003 · Cited by 559
Foy, E., Li, K., Sumpter, R., Loo, Y.-M., Johnson, C. L., Wang, C., Fish, P. M., Yoneyama, M., Fujita, T., Lemon, S. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408707102 · Cited by 548
Muir, A. J., Bornstein, J. D., & Killenberg, P. G. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032502 · Cited by 541
Pegylated interferon-α2b: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data
Glue, P. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.110973 · Cited by 504
Chen, L., Borozan, I., Feld, J., Sun, J., Tannis, L.-L., Coltescu, C., Heathcote, J., Edwards, A. M., & McGilvray, I. D. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.01.059 · Cited by 453
Self-citationEffect of Alpha Interferon on the Hepatitis C Virus Replicon
Guo, J.-T., Bichko, V. V., & Seeger, C. (2001) · Journal of Virology · doi:10.1128/jvi.75.18.8516-8523.2001 · Cited by 443
DNA Microarray Analysis of Chimpanzee Liver during Acute Resolving Hepatitis C Virus Infection
Bigger, C. B., Brasky, K. M., & Lanford, R. E. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.7059-7066.2001 · Cited by 442
Lambda Interferon Inhibits Hepatitis B and C Virus Replication
Robek, M. D., Boyd, B. S., & Chisari, F. V. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3851-3854.2005 · Cited by 431
Modelling how ribavirin improves interferon response rates in hepatitis C virus infection
Dixit, N. M., Layden-Almer, J. E., Layden, T. J., & Perelson, A. S. (2004) · Nature · doi:10.1038/nature03153 · Cited by 369
Mechanism of action of ribavirin in the combination treatment of chronic HCV infection
Lau, J. Y. N., Tam, R. C., Liang, J. T., & Hong, Z. (2002) · Hepatology · doi:10.1053/jhep.2002.32672 · Cited by 337
Ribavirin as Therapy for Chronic Hepatitis C: A Randomized, Double-Blind, Placebo-Controlled Trial
Di Bisceglie, A. M., Conjeevaram, H. S., Fried, M. W., Sallie, R., Park, Y., Yurdaydin, C., Swain, M., Kleiner, D. E., Mahaney, K., & Hoofnagle, J. H. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-12-199512150-00001 · Cited by 328
Self-citationPolyak, S. J., Khabar, K. S. A., Paschal, D. M., Ezelle, H. J., Duverlie, G., Barber, G. N., Levy, D. E., Mukaida, N., & Gretch, D. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.6095-6106.2001 · Cited by 323
Interferon-γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs
Frese, M., Schwärzle, V., Barth, K., Krieger, N., Lohmann, V., Mihm, S., Haller, O., & Bartenschlager, R. (2002) · Hepatology · doi:10.1053/jhep.2002.31770 · Cited by 314
Cramp, M. E., Rossol, S., Chokshi, S., Carucci, P., Williams, R., & Naoumov, N. V. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70217-4 · Cited by 313
Optimal therapy of hepatitis C
Di Bisceglie, A. M., & Hoofnagle, J. H. (2002) · Hepatology · doi:10.1002/hep.1840360716 · Cited by 297
Self-citationExpression of Hepatitis C Virus Proteins Inhibits Signal Transduction through the Jak-STAT Pathway
Heim, M. H., Moradpour, D., & Blum, H. E. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8469-8475.1999 · Cited by 287
Maag, D., Castro, C., Hong, Z., & Cameron, C. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100349200 · Cited by 281
10-year follow-up after interferon-α therapy for chronic hepatitis C
Lau, D. T., Kleiner, D. E., Ghany, M. G., Park, Y., Schmid, P., & Hoofnagle, J. H. (1998) · Hepatology · doi:10.1002/hep.510280430 · Cited by 266
Self-citationAntiviral action of ribavirin in chronic hepatitis C
Pawlotsky, J., Dahari, H., Neumann, A. U., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.002 · Cited by 262
Intrahepatic Gene Expression during Chronic Hepatitis C Virus Infection in Chimpanzees
Bigger, C. B., Guerra, B., Brasky, K. M., Hubbard, G., Beard, M. R., Luxon, B. A., Lemon, S. M., & Lanford, R. E. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13779-13792.2004 · Cited by 259
Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C.
McHutchison, J. G., & Poynard, T. (1999) · PubMed · Cited by 243
Polyak, S. J., Khabar, K. S. A., Rezeiq, M., & Gretch, D. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.6209-6211.2001 · Cited by 243
Wang, C., Pflugheber, J., Sumpter, R., Sodora, D. L., Hui, D., Sen, G. C., & Gale, M. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.3898-3912.2003 · Cited by 231
Lanford, R. E., Guerra, B., Lee, H., Averett, D. R., Pfeiffer, B., Chavez, D., Notvall, L., & Bigger, C. (2003) · Journal of Virology · doi:10.1128/jvi.77.2.1092-1104.2003 · Cited by 216
Lindahl, K., Ståhle, L., Bruchfeld, A. N., & Schvarcz, R. (2005) · Hepatology · doi:10.1002/hep.20563 · Cited by 215
Interferon-α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway
Frese, M., Pietschmann, T., Moradpour, D., Haller, O., & Bartenschlager, R. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-4-723 · Cited by 211
Tilg, H. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9041265 · Cited by 204
Mini ReviewHuman Interferons Alpha, Beta and Omega
Bekisz, J., Schmeisser, H., Hernandez, J., Goldman, N. D., & Zoon, K. C. (2004) · Growth Factors · doi:10.1080/08977190400000833 · Cited by 194
Kamal, S. M., Fehr, J., Roesler, B., Peters, T., & Rasenack, J. W. (2002) · Gastroenterology · doi:10.1053/gast.2002.36045 · Cited by 193
Contreras, A. M., Hiasa, Y., He, W., Terella, A., Schmidt, E. V., & Chung, R. T. (2002) · Journal of Virology · doi:10.1128/jvi.76.17.8505-8517.2002 · Cited by 188
Young, K.-C., Lindsay, K. L., Lee, K.-J., Liu, W.-C., He, J.-W., Milstein, S. L., & Lai, M. M. C. (2003) · Hepatology · doi:10.1002/hep.1840380413 · Cited by 186
Layden-Almer, J. E., Ribeiro, R. M., Wiley, T., Perelson, A. S., & Layden, T. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50217 · Cited by 184
The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA
Zhou, S., Liu, R., Baroudy, B. M., Malcolm, B. A., & Reyes, G. R. (2003) · Virology · doi:10.1016/s0042-6822(03)00152-1 · Cited by 180
Blindenbacher, A., Duong, F. H. T., Hunziker, L., Stutvoet, S. T. D., Wang, X., Terracciano, L., Moradpour, D., Blum, H. E., Alonzi, T., Tripodi, M., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00290-7 · Cited by 178
Kamal, S. M., Ismail, A., Graham, C. S., He, Q., Rasenack, J. W., Peters, T., Tawil, A. A., Fehr, J. J., Khalifa, K. E. S., Madwar, M. M., et al. (2004) · Hepatology · doi:10.1002/hep.20266 · Cited by 163
Ribavirin Induces Error-Prone Replication of GB Virus B in Primary Tamarin Hepatocytes
Lanford, R. E., Chavez, D., Guerra, B., Lau, J. Y. N., Hong, Z., Brasky, K. M., & Beames, B. (2001) · Journal of Virology · doi:10.1128/jvi.75.17.8074-8081.2001 · Cited by 154
Santantonio, T. A., Fasano, M., Sinisi, E., Guastadisegni, A., Casalino, C., Mazzola, M., Francavilla, R., & Pastore, G. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.021 · Cited by 151
Effects of antiviral therapy on the cellular immune response in acute hepatitis C
Rahman, F., Heller, T., Sobao, Y., Mizukoshi, E., Nascimbeni, M., Alter, H. J., Herrine, S. K., Hoofnagle, J. H., Liang, J. T., & Rehermann, B. (2004) · Hepatology · doi:10.1002/hep.20253 · Cited by 145
Self-citationThe α Chemokine, Interleukin 8, Inhibits the Antiviral Action of Interferon α
Khabar, K. S. A., Al-Zoghaibi, F., Al‐Ahdal, M. N., Murayama, T., Dhalla, M., Mukaida, N., Taha, M., Al‐Sedairy, S. T., Siddiqui, Y. M., Kessie, G., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1077 · Cited by 133
Ji, X., Cheung, R. C., Cooper, S., Li, Q. S., Greenberg, H. B., & He, X.-S. (2003) · Hepatology · doi:10.1053/jhep.2003.50105 · Cited by 128
Zhang, Y., Jamaluddin, M., Wang, S., Tian, B., Garofalo, R. P., Casola, A., & Brasier, A. R. (2003) · Journal of Virology · doi:10.1128/jvi.77.10.5933-5947.2003 · Cited by 109
Gene Expression Associated With Interferon Alfa Antiviral Activity in An Hcv Replicon Cell Line
Zhu, H., Zhao, H., Collins, C. D., Eckenrode, S., Run, Q.-G., McIndoe, R., Crawford, J. M., Nelson, D. R., She, J., & Liu, C. (2003) · Hepatology · doi:10.1053/jhep.2003.50184 · Cited by 104
Thomson, M., Nascimbeni, M., Havert, M. B., Major, M. E., Gonzales, S., Alter, H. J., Feinstone, S. M., Murthy, K. K., Rehermann, B., & Liang, T. J. (2002) · Journal of Virology · doi:10.1128/jvi.77.2.862-870.2003 · Cited by 93
Pavio, N., Taylor, D. R., & Lai, M. M. C. (2002) · Journal of Virology · doi:10.1128/jvi.76.3.1265-1272.2002 · Cited by 92
Understudied populations with hepatitis C
Strader, D. B. (2002) · Hepatology · doi:10.1002/hep.1840360729 · Cited by 78
Girard, S., Shalhoub, P., Lescure, P., Sabile, A., Misek, D. E., Hanash, S., Bréchot, C., & Beretta, L. (2002) · Virology · doi:10.1006/viro.2002.1373 · Cited by 72
Fiedler, M. A., Wernke-Dollries, K., & Stark, J. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.9079-9082.1996 · Cited by 68
Mechanism of the interferon alpha response against hepatitis C virus replicons
Guo, J., Sohn, J. A., Zhu, Q., & Seeger, C. (2004) · Virology · doi:10.1016/j.virol.2004.04.031 · Cited by 66
Basu, A., Meyer, K., Ray, R. B., & Ray, R. (2001) · Virology · doi:10.1006/viro.2001.1100 · Cited by 60
Signal transduction and activation of gene transcription by interferons.
Gilmour, K. C., & Reich, N. C. (1995) · Europe PMC (PubMed Central) · Cited by 53
Lau, B. W., Colella, M., Ruder, W. C., Ranieri, M., Curci, S., & Hofer, A. M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.046 · Cited by 51
Effector Genes of Interferon Action Against Hepatitis C Virus
Gale, M. (2003) · Hepatology · doi:10.1053/jhep.2003.50201 · Cited by 37
Cited by
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
Bacon, B. R., Gordon, S. C., Lawitz, E., Marcellin, P., Vierling, J. M., Zeuzem, S., Poordad, F., Goodman, Z. D., Sings, H. L., Boparai, N., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009482 · Cited by 1,626
Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection
Lanford, R. E., Hildebrandt-Eriksen, E. S., Petri, A., Persson, R., Lindow, M., Munk, M. E., Kauppinen, S., & Ørum, H. (2010) · Science · doi:10.1126/science.1178178 · Cited by 1,459
Gordon, C. J., Tchesnokov, E. P., Woolner, E., Perry, J. K., Feng, J. Y., Porter, D. P., & Götte, M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013679 · Cited by 985
Kamar, N., Dalton, H. R., Abravanel, F., & Izopet, J. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00057-13 · Cited by 675
Metadata
- Authors
- Feld, J. J., & Hoofnagle, J. H.
- Venue
- Nature
- Published
- 2005-08
- Volume
- 436
- Issue
- 7053
- Pages
- 967-972
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2029323175
- Cited by
- 992
- References
- 79
- FWCI
- 37.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.